A hypothesis may be raised: further enhancement of the action of ANP could also be a strategy for those at high risk of CKD [27]; however, neither the natriuretic peptides nor NEP inhibitors have been directly proven to be effective in suppressing the development or progression of CKD in humans. Here, MME is linked to chronic kidney disease.